Salvaging Percutaneously a Suboptimal TAVR Deployment with Repositioning In the Thoracic Aorta: A Novel Snare-Mediated Approach to Prosthesis Malposition. [PDF]
Patel SM +9 more
europepmc +1 more source
Hydra valve with active release mechanism: GENESIS of a new contender in TAVI space. [PDF]
Daggubati R, Chaturvedi A.
europepmc +1 more source
Live Hemodynamics-Assisted Simultaneous Aortic and Mitral Valve-in-Valve Replacement. [PDF]
Mengi S +3 more
europepmc +1 more source
Transcatheter Aortic Valve Replacement and Percutaneous Coronary Intervention After Ozaki Procedure in Alagille Syndrome. [PDF]
Mayr B +8 more
europepmc +1 more source
Major Bleeding and Thromboembolic Events with the On-X Mechanical Aortic Valve Prosthesis: A SWEDEHEART Study. [PDF]
Lu R +4 more
europepmc +1 more source
Thrombolysis in dysfunctional valve and stroke. [PDF]
Barrios-Martínez DD +3 more
europepmc +1 more source
Comparison of Surgical Treatment Outcomes in Patients with Symptomatic Severe Aortic Valve Stenosis Using the Perceval Sutureless Bioprosthesis Versus a Conventional Biological Valve. [PDF]
Lazović DM +8 more
europepmc +1 more source
Persistent Hematuria With Late Diagnosis of Cardiac Origin: A Case Report. [PDF]
Hamilton N, Hingorany S, Mazar M.
europepmc +1 more source
Totally endoscopic mitral valve replacement for mitral regurgitation post-transcatheter aortic valve implantation: a case report. [PDF]
Goto Y +3 more
europepmc +1 more source
Related searches:
Mechanical heart valve prosthesis and warfarin - treatment quality and prognosis.
Thrombosis Research, 2014Every year about 2500 patients in Sweden undergo surgery due to heart valve disease. A mechanical heart valve prosthesis causes risk of thromboembolic stroke or thrombus formation in the valve while anticoagulant treatment increases the risk of bleeding. Treatment quality with warfarin is crucial for patients with mechanical valve prostheses.
B. Grzymala-Lubanski +4 more
semanticscholar +4 more sources

